Top ONE Network news of 2018

From recalls to regulatory approvals, here's a look at the year's most-viewed clinical news stories and Editors' Choice coverage.

Headlines

1. Alcon voluntarily withdraws CyPass microstent

By Anni Griswold
Alcon has announced an immediate, voluntary market withdrawal of the CyPass microstent for surgical glaucoma from the global market.
Aug 28, 2018

2. Ketogenic diet may prevent optic nerve degeneration in glaucoma

By Anni Griswold
New findings suggest a low-carb, high-fat diet may guard against glaucoma—at least in mice.
May 24, 2018

3. Alert: Regeneron halts distribution of Eylea kits with affected syringes

By Keng Jin Lee
A recent spike in cases of intraocular inflammation among patients receiving aflibercept (Eylea) appear linked with specific batches of syringes, according to Regeneron Pharmaceuticals.
March 12, 2018

4. FDA approves first neurotrophic keratitis drug

By Kanaga Rajan
Following a priority review, the FDA has cleared cenergermin (Oxervate), a first-in-class treatment for moderate or severe neurotrophic keratitis.
Aug 23, 2018

5. Eye drop improves near vision in presbyopia patients

By Kanaga Rajan
A mid-stage study of a miotic topical solution shows that it safely improves near vision in people with presbyopia, according to a press release by Presbyopia Therapies, LLC.
Aug 01, 2018

Editors' Choice

1. Novel treatment restores corneal clarity in patients with bullous keratopathy

By Julie M. Schallhorn, MD
Researchers from Japan treated bullous keratopathy with an injection of cultured human corneal endothelial cells (CECs) supplemented with a Rho-associated protein kinase (ROCK) inhibitor.
Apr 16, 2018

2. Sunlight exposure reduces myopia in children

By Aparna Ramasubramanian, MD
This cluster-randomized, intervention-controlled study examined the effect of a school-based program encouraging outdoor activities on myopia.
Aug 19, 2018

3. Top 11 uveitis papers for residents in 2017

Edited by Justine Smith, MD
Eleven uveitis papers, published in 2017, were selected by members of the American Uveitis Society for their outstanding teaching value for residents.
Dec 11, 2018

4. Antiseptic-steroid combination drops show promise for treating acute adenoviral conjunctivitis

By Wuqaas M. Munir, MD
Researchers evaluated the efficacy and safety of a povidone-iodine (PVP-I)-dexamethasone treatment for acute adenoviral conjunctivitis.
Oct 22, 2018

5. Oral and IV corticosteroids equivalent for acute optic neuritis

By Michael S. Vaphiades, DO
This randomized clinical trial compared the efficacy of high-dose intravenous (IV) corticosteroids with a bioequivalent dose of oral corticosteroids for the treatment of acute optic neuritis.
May 29, 2018